Nuclera exists to remove uncertainty from protein science. As the pioneer of multiplex protein screening, the company helps researchers start with clarity, so ideas move faster to result. Nuclera believes access to your protein should be a certainty, not a gamble. eProtein Discovery™ is how they deliver on that promise, but our aim is bigger: to make protein access routine for every lab, accelerate breakthroughs in human health, and empower scientists to spend more time on discovery and less on delay.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
01/15/26	$12,000,000	Series C	British Business Bank Elevage Medical Technologies GK Goh Jonathan Milner	undisclosed